Inflation Devices

Global Inflation Devices Market to Reach US$1.0 Billion by 2030

The global market for Inflation Devices estimated at US$732.8 Million in the year 2024, is expected to reach US$1.0 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. 20ml, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$424.7 Million by the end of the analysis period. Growth in the 30ml segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$190.5 Million While China is Forecast to Grow at 8.9% CAGR

The Inflation Devices market in the U.S. is estimated at US$190.5 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$236.1 Million by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Inflation Devices Market - Key Trends and Drivers Summarized

Why Are Inflation Devices Important in Minimally Invasive Procedures?

Inflation devices are essential tools used in minimally invasive medical procedures, particularly in angioplasty, stent placement, and balloon catheterization. These devices help regulate and control the inflation of balloons or other devices used to open blocked or narrowed blood vessels, ensuring that the procedure is performed safely and effectively. Inflation devices are commonly used in cardiology, urology, and gastroenterology procedures, where precision and control are critical to avoid complications. By providing accurate pressure readings and controlled inflation, these devices play a crucial role in reducing procedural risks and improving patient outcomes in both diagnostic and therapeutic interventions.

How Are Technological Advancements Shaping the Inflation Devices Market?

Technological innovations are significantly enhancing the design and functionality of inflation devices, making them more accurate, user-friendly, and versatile. The development of digital inflation devices with enhanced pressure monitoring and automatic inflation capabilities is improving procedural precision, allowing healthcare providers to make real-time adjustments during interventions. Advances in materials science are also contributing to the creation of more durable and lightweight devices, which improve handling and reduce operator fatigue during lengthy procedures. Additionally, innovations in ergonomic design and the integration of pressure limiters are enhancing the safety profile of these devices, ensuring that balloons are inflated to the optimal pressure levels to avoid vessel damage.

How Do Market Segments Define the Growth of the Inflation Devices Market?

Product types include analog and digital inflation devices, with digital devices gaining market share due to their enhanced accuracy and ease of use. Applications include cardiology, gastroenterology, and urology, with cardiology being the largest segment as inflation devices are frequently used in procedures such as angioplasty and stent deployment. End-users include hospitals, ambulatory surgical centers, and specialized clinics, with hospitals representing the largest market share due to the high volume of cardiovascular and urological procedures performed in these settings. The market is growing rapidly in developed regions like North America and Europe, where advanced healthcare infrastructure and increasing rates of minimally invasive surgeries are driving demand.

What Factors Are Driving the Growth in the Inflation Devices Market?

The growth in the inflation devices market is driven by several factors, including the rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive procedures, and technological advancements in device design. Cardiovascular diseases, such as coronary artery disease and peripheral artery disease, are among the leading causes of mortality worldwide, driving demand for angioplasty and stent placement procedures, where inflation devices are essential. The growing trend toward minimally invasive surgeries, which offer faster recovery times and reduced complications compared to open surgeries, is also contributing to market growth. Furthermore, technological innovations that improve the accuracy, safety, and ease of use of inflation devices are enhancing their adoption in a wide range of medical procedures. The increasing geriatric population and the rising number of healthcare facilities in emerging markets are further boosting demand for these devices.

SCOPE OF STUDY:

The report analyzes the Inflation Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Capacity (20ml, 30ml, 60ml); Display Type (Analog, Digital); Application (Peripheral Vascular Procedures, Gastroenterological Procedures, Urological Procedures, Intervention Cardiology & Radiology)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Acclarent Inc.
• Advanced Lifesciences Pvt. Ltd.
• Atrion Corporation
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Cardinal Health
• Conmed Corporation
• Cook Medical
• Medtronic PLC
• Merit Medical Systems
• Olympus Corporation
• Teleflex Incorporated
• Terumo Medical Corporation
• US Endovascular

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.